Elanco Animal Health IncELAN
Price$21.77Intrinsic value$16.5824% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $5B+13.1% YoYTTM through 30 Jun 2026
Net Income -$199M-158.9% YoYTTM through 30 Jun 2026
Free Cash Flow $379MTTM through 30 Jun 2026

Margins

Current
Gross Margin57.3%
EBITDA Margin10.5%
Operating Margin10.5%
Net Margin-4.0%

Returns

0.9%ROE
0.4%ROA

Balance Sheet Health

Debt / Equity0.61x
Current Ratio2.16x
Net Debt$3.3B
Cash & Equivalents$530M

Quality Metrics

Altman Z-Score1.27
Piotroski F-Score5 / 9
FCF Margin7.5%
Rule of 409.6
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $4.7B
Diluted EPS-$0.41TTM
'19'20'21'22'23'24'25
FY2025: $-0.47

Dividend

No dividend

Capital Allocation

R&D Spend$371M
Capex Intensity4.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.